Showing results (631-640 of 26,310) with videos related to
Sort By:
Pageof 2,631
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Phthalazine PDE4 inhibitors. Part 3: the synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptorMauro Napoletano, Gabriele Norcini, Franco Pellacini, et al.Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Minimal structural requirements for agonist activity of PAR-2 activating peptidesVincenzo Santagada, Giuseppe Caliendo, Beatrice Severino, et al.Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacementsPaul J Coleman, Karen M Brashear, Cecilia A Hunt, et al.Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.Bioorganic & Medicinal Chemistry Letters|December 12, 2001
3-D QSAR studies on new dibenzyltin(IV) anticancer agents by comparative molecular field analysis (CoMFA)Purnima M Samuel, Dick de Vos, D Raveendra, et al.Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptorsChristopher A Willoughby, Steven M Hutchins, Keith G Rosauer, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weightK G Liu, M H Lambert, A H Ayscue, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 2001
4-Aminopiperidine ureas as potent selective agonists of the human beta(3)-adrenergic receptorM A Ashwell, W R Solvibile, S Han, et al.Bioorganic & Medicinal Chemistry Letters|November 27, 2001
Modelling studies of the active site of human sorbitol dehydrogenase: an approach to structure-based inhibitor design of the enzymeC Darmanin, O El-KabbaniBioorganic & Medicinal Chemistry Letters|November 27, 2001
Combinatorial synthesis of CCR5 antagonistsC A Willoughby, S C Berk, K G Rosauer, et al.Pageof 2,631